# Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

> **NCT05916469** · — · RECRUITING · sponsor: **Oregon Health and Science University** · enrollment: 300 (estimated)

## Conditions studied

- Heavy Menstrual Bleeding
- Bleeding Disorder
- Von Willebrand Diseases

## Interventions

- **DRUG:** Levonorgestrel Intrauterine System
- **DRUG:** Norethindrone Acetate

## Key facts

- **NCT ID:** NCT05916469
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-24
- **Primary completion:** 2028-12
- **Final completion:** 2029-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-12-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05916469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05916469, "Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05916469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*